Object of the contract
It is not an open procedure, but a so-called. Open-house-model! The form for the open procedure is only used is because no form for the open-house model exists. AOK Bayern assumes that contracts which are concluded in the open-house model, lack of selection decision not fall under the public procurement law.A submission to procurement law arrangements with using this form not verbunden.Die AOK Bavaria intends with all interested pharmaceutical companies non-exclusive discount agreements by the drug bupropion (N06AX12) pursuant to i?1/2 130a para. 8 to close SGB V. AOK Bavaria offers all interested pharmaceutical subtake that fulfill the mentioned below eligibility requirements, the completion of identical and not individually negotiable discount agreements on. The fruehestmoegliche inception, the 01.06.2016, all contracts end on 31/05/2018. A contract is during this duration at any time possible, no later, however, on 06/04/2018. The contracts canbe rescinded within a period of one month to the end of the month. In an about by nationwide or country-specific, closed the open procedure Off Treaty medicine called bupropion (N06AX12) entry into force of the open-house arrangements occur automatically for the same duration to lapse. Interested pharmaceutical enterprisesta king could share the contract documents at the address given in I.1) Request contact point. A contract is with all interested pharmaceutical companies concluded that demonstrate their suitability as follows :: (request form in I.1) Self-Declaration on the reliability designated point): the current (at the entrance not older than 6 months)i?1/2Professional or commercial register in accordance with the legislation of the country in which the supplier is ansa vinegar. They may also have printouts from the electronic commercial register (www.handelsregister.de). Here is the "current expression" (AD) with an overview of all currently valid entries or the "chronological term" (CD) with alli?1/2to choose data from switch to electronic Registerfuehrung. In limited partnerships, the above evidence excerpt from the Public part (AJ 29) of AMIS database, the drug information system of the German Institute for Medical Documentation and Information is additionally to provide for the personally liable shareholder .: (DIMDI) for all medicinal products, for which the pharmaceutical company offering discounts (which will bring the pharmaceutical company in accordance with its declaration under Annex 1 to the discount agreement at the beginning of the discount contract in traffic). It must be made of the extracts, the following information about the current registration situation of all future Rabattarzneimittel result: a. Name / designation of the medicinal product, b. Name of the authorization holder (alternatively:. Name of authorized for other reasons for marketing the medicinal product Holder within the meaning of i?1/2 4 para 18 sentence 2 AMG and stating the reason this permission), the position of just the vendor as a pharmaceutical companymust be demonstrated in terms of the drugs offered by it: otherwise, an affidavit accompanied, according to which the provider is entitled to the marketing of the product in Germany, c. Dosage form, d. Active substance, e. Information to Verkehrsfaehigkeit.Soweit at a drug angebotsgegenstaendlichen current to thelassungsrechtliche situation with regard to under points a required to e information is different from the last stand available in the public part of the AMIS database for tender and to the extent neither the free nor the costs available extract from the Public part (AJ 29) of AMIS database all under points a to ei?1/2necessary information identifies completely, the provider the current state or the missing information has by presentation of appropriate augmentative evidence (eg copy of the admission notice, copies of Aenderungsanzeigen, affidavit, etc.) together with the extract from the Public part (AJ 29) of AMIS database credible to dowerden.Der en.Unterlagen that are not written in German, must with a German translation filed marketing authorization holder has to be requested to at the address in I.1) contact point completed and signed (the power of representation of / the undersigned / s must be made the certificate of registration shown otherwisei?1/2is to present a power of attorney) Contract and ausgefuellter Appendix 1 and Appendix 2 in 3-fold version in the original as well as the aforementioned Eignungsnachweise be sent to the following address: AOK Bayern: The Gesundheitskasse Vergabestelle open house RabattvertraegeCarl-Wery-Str. 2881739 MuenchenBei input conplete and correct documents to 06 of each Monats the start of the contract is carried out for the following next month first, otherwise the following next but first of the month. A copy of the complete, completed and signed documents in advance by fax (089/62730650151) or scan to the e-mail address is
[email protected] period-protecting.
Description: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union, with participation by GPA countries
Award criteria: Not specified
CPV code: 33600000
CPV Description: Pharmaceutical products.
Internet address (URL): http://www.aok.de
Directive: Classical Directive (2004/18/EC)
Sign in with Google